Fig. (1) Trend profiles of foveal thickness and volume after intravitreal injection of triamcinolone acetonide (IVTA) in BRVO patients with macular oedema. (A) In the Major group and the Macular group, the foveal thickness decreased significantly from before IVTA to 3 and 6 months after IVTA (P<0.001 and P<0.001, respectively). There was no significant difference in the trend profile of foveal thickness between the two groups (P=0.457). (B) In the Major group and the Macular group, the foveal volume decreased significantly from before IVTA to 3 and 6 months after IVTA (P<0.001 and P<0.001, respectively). There was no significant difference in the trend profile of foveal volume between the two groups (P=0.476).